3.5% formalin™ (Miles Laboratories)
90
Structured Review
Miles Laboratories
3.5% formalin™
3.5% Formalin™, supplied by Miles Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/formalin+solution/buffered+10++formalin+solution/us08008321-426-19-24
Average 90 stars, based on 1 article reviews
3.5% Formalin™, supplied by Miles Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/formalin+solution/buffered+10++formalin+solution/us08008321-426-19-24
Average 90 stars, based on 1 article reviews
3.5% formalin™ - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same Article Snippet: 14 days later, the Article Title: The beneficial effect of coenzyme Q10 and lipoic acid on obstructive bladder dysfunction in the rabbit. Article Snippet: Yung-Shun Juan, Robert M. Levin, Shu Mien Chuang, Tasmina Hydery, Suning Li, Barry Kogan, Catherine Schuler, Chun-Hsiung Huang and Anita Mannikarottu* From the Kaohsiung Municipal Hsiao-Kang Hospital, Graduate Institute of Medicine, College of Medicine and Department of Urology (SMC, CHH), Kaohsiung Medical University, Kaohsiung (YSJ), Taiwan, Republic of China, First Affiliated Hospital of Zhengzhou University (SL, CS), Henan, People’s Republic of China, and Albany College of Pharmacy (TH, CS, AM), Albany Medical College (BK, AM) and Stratton Veterans Affairs Medical Center, Albany (RML), New York Article Title: Imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same Article Snippet: 14 days later, the Immunohistochemical staining:Article Title: E7080, a Multi-Tyrosine Kinase Inhibitor, Suppresses the Progression of Malignant Pleural Mesothelioma with Different Proangiogenic Cytokine Production Profiles Article Snippet: .. The tumors were cut into 5-mm fragments and placed into either buffered 10% Article Title: The Therapeutic Efficacy of Anti–Vascular Endothelial Growth Factor Antibody, Bevacizumab, and Pemetrexed against Orthotopically Implanted Human Pleural Mesothelioma Cells in Severe Combined Immunodeficient Mice Article Snippet: .. The thoracic tumors were cut into 5-mm fragments and placed into either a buffered 10% Article Title: SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model. Article Snippet: Background and objective: Malignant pleural mesothelioma (MPM) is an aggressive neoplasm of the mesothelium with high chemotherapeutic resistance.. In this study, the preclinical therapeutic activity of the multiple tyrosine kinase inhibitor, SU6668, against MPM was examined.. Methods: Two human MPM cell lines with different pro-angiogenic cytokine expression, Y-MESO-14 cells that express high levels of vascular endothelial growth factor (VEGF) and MSTO-211H cells that express high levels of basic fibroblast growth factor (bFGF), were orthotopically inoculated into the thoracic cavities of mice with severe combined immunodeficiency. Article Title: Antitumor Vascular Strategy for Controlling Experimental Metastatic Spread of Human Small-Cell Lung Cancer Cells with ZD6474 in Natural Killer Cell–Depleted Severe Combined Immunodeficient Mice Article Snippet: .. The major organs with metastases were cut into 5-mm fragments and placed into either buffered 10% |